Lobbying disclosures · Lobbying report
WAT: third_quarter 2026 lobbying report
Commerce Dept. Bureau of Industry and Security export control regulations on high-parameter flow cytometers and related biotechnology equipment (RIN 0694-AJ95; Docket BIS-2024-0050) Commerce Dept. Bureau of Industry and Security export control regulations on high-parameter flow cytometers and related biotechnology equipment (RIN 0694-AJ95; Docket BIS-2024-0050)
Follow WAT- Became public
- Sep 23, 2026, 4:16 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 10, 2026, 8:47 PM EST
Why this is connected
Exact legal-name match: WATERS CORP /DE/ (https://www.sec.gov/Archives/edgar/data/1000697/).
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/0914dd59-a665-428f-b5d3-75a8bcfd6781/","filing_uuid":"0914dd59-a665-428f-b5d3-75a8bcfd6781","filing_type":"RR","filing_type_display":"Registration","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/0914dd59-a665-428f-b5d3-75a8bcfd6781/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Heather Meade","dt_posted":"2026-09-23T16:16:45-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1101 New York Avenue, NW","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":57475,"url":"https://lda.gov/api/v1/registrants/57475/","house_registrant_id":35185,"name":"ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG)","description":"Professional services firm","address_1":"1101 New York Avenue, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ROBB CANNING","contact_telephone":"+1 860-725-3895","dt_updated":"2026-07-21T15:03:19.787154-04:00"},"client":{"id":75071,"url":"https://lda.gov/api/v1/clients/75071/","client_id":75071,"name":"WATERS CORP.","general_description":"Maker of analytical instruments and software used by life sciences labs","client_government_entity":null,"client_self_select":false,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-09-17"},"lobbying_activities":[{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Commerce Dept. Bureau of Industry and Security export control regulations on high-parameter flow cytometers and related biotechnology equipment (RIN 0694-AJ95; Docket BIS-2024-0050)","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":153520,"prefix":null,"prefix_display":null,"first_name":"BLAKE","nickname":null,"middle_name":null,"last_name":"HARDEN","suffix":null,"suffix_display":null},"covered_position":"Senior Attorney, U.S. Customs and Border Protection, 2006-2016; Trade Counsel, House Ways & Means Committee, 2016-19","new":true},{"lobbyist":{"id":49382,"prefix":null,"prefix_display":null,"first_name":"HEATHER","nickname":null,"middle_name":null,"last_name":"MEADE","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":155166,"prefix":null,"prefix_display":null,"first_name":"HEATHER","nickname":null,"middle_name":null,"last_name":"BELL","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Commerce Dept. Bureau of Industry and Security export control regulations on high-parameter flow cytometers and related biotechnology equipment (RIN 0694-AJ95; Docket BIS-2024-0050)","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":153520,"prefix":null,"prefix_display":null,"first_name":"BLAKE","nickname":null,"middle_name":null,"last_name":"HARDEN","suffix":null,"suffix_display":null},"covered_position":"Senior Attorney, U.S. Customs and Border Protection, 2006-2016; Trade Counsel, House Ways & Means Committee, 2016-19","new":true},{"lobbyist":{"id":49382,"prefix":null,"prefix_display":null,"first_name":"HEATHER","nickname":null,"middle_name":null,"last_name":"MEADE","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":155166,"prefix":null,"prefix_display":null,"first_name":"HEATHER","nickname":null,"middle_name":null,"last_name":"BELL","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in WAT
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Sep 1, 2026$1K–$15K
Rep. Kevin Hern (R-OK-1)
$1K–$15K · Traded Aug 13, 2026 · disclosed Sep 1, 2026 · Joint
- May 11, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Apr 13, 2026 · disclosed May 11, 2026 · Spouse
- Apr 13, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
$1K–$15K · Traded Mar 10, 2026 · disclosed Apr 13, 2026
Committee overlap: Energy and Commerce - Apr 7, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Mar 18, 2026 · disclosed Apr 7, 2026
- Mar 18, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
$1K–$15K · Traded Feb 13, 2026 · disclosed Mar 18, 2026
Committee overlap: Energy and Commerce - Mar 6, 2026$1K–$15K
Rep. Kevin Hern (R-OK-1)
$1K–$15K · Traded Feb 9, 2026 · disclosed Mar 6, 2026 · Joint
- Feb 23, 2026$1K–$15K
Rep. Debbie Dingell (D-MI-6)
$1K–$15K · Traded Feb 10, 2026 · disclosed Feb 23, 2026
Committee overlap: Energy and Commerce - Jan 13, 2026$1K–$15K
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.